Jyong Bio (MENS) - Koefisien utang jangka dawa marang modal

Jyong Bio - logo grafis emiten MENS

The daily price chart for Jyong Biotech Ltd (MENS) shows a figure of 0.00, a critical factor when analyzing the business's dependence on external manufacturing contractors. The Taiwanese company generates revenue from the creation of urological products, utilizing a licensing model to minimize capital expenditures. The brand's innovative image in botanical medicine helps the firm attract capital and the trust of specialists.

Jyong Biotech Limited (MENS): Utang jangka dawa marang ekuitas saka 18.06.2025 nganti 31.10.2026
Produk mawa merek Jyong Biotech Ltd

Funding advanced laboratories and retaining highly qualified biologists at Jyong Biotech Ltd (MENS) requires significant long-term infrastructure investments. By analyzing the long-term debt-to-equity ratio, an investor assesses the proportion of liabilities with maturities exceeding one year relative to equity, which determines the company's level of dependence on external borrowings and the overall stability of its financial foundation.

Analisis perusahaan pesaing

Haleon PLC - Kewajiban jangka dawa marang ekuitas|Utang jangka dawa marang modal KVUE|VRNA (Verona Pharma Inc.) - Koefisien utang jangka dawa marang modal|Utang jangka dawa marang modal LGND (Ligand Pharmaceuticals)|Utang jangka dawa marang modal amneal.com AMRX|PRGO - Utang jangka dawa marang ekuitas|Koefisien utang jangka dawa marang modal ALVO (Alvotech S.A.)|Liquidia Technologies (LQDA) - Utang jangka dawa marang ekuitas|Rasio utang jangka dawa marang ekuitas Galapagos Corp|ANIP (ANI Pharmaceuticals) - Utang jangka dawa marang modal|Utang jangka dawa marang modal mannkindcorp.com|Rasio utang jangka dawa marang ekuitas AMPH (Amphastar Pharmaceuticals, Inc.)|PCRX (Pacira Pharmaceuticals) - Koefisien utang jangka dawa marang modal|Utang jangka dawa marang ekuitas ARS Pharma SPRY|Theravance Corp (TBPH) - Kewajiban jangka dawa marang modal|AQST: Rasio utang jangka dawa marang ekuitas|scPharmaceuticals Inc. - Rasio silihan jangka dawa marang modal|TECX: Utang jangka dawa marang modal|Tonix Pharma - Koefisien utang jangka dawa marang modal|SXTC (SXT Pharmaceuticals) - Utang jangka dawa marang modal|Kewajiban jangka dawa marang modal Eupraxia Pharma EPRX|Utang jangka dawa marang ekuitas BioHarvest Sciences (BHST)|EXOZ (invizyne.com) - Koefisien utang jangka dawa marang modal|Utang jangka dawa marang ekuitas Oramed Pharmaceuticals Inc. ORMP|Rasio silihan jangka dawa marang modal ENTX (Entera Bio Ltd)|HYFT: Rasio utang jangka dawa marang ekuitas|Kewajiban jangka dawa marang modal ABVC BioPharma, Inc|Cumberland Pharmaceuticals (CPIX) - Utang jangka dawa marang ekuitas|Kewajiban jangka dawa marang modal quantumbiopharma.com (QNTM)|Utang jangka dawa marang ekuitas FibroGen|Rasio utang jangka dawa marang modal TELO (Telomir Pharmaceuticals Inc)|Utang jangka dawa marang modal RANI|synergychc.com (SNYR) - Tanggungan utang jangka dawa marang ekuitas|Rallybio - Rasio utang jangka dawa marang ekuitas|Koefisien utang jangka dawa marang modal LEXX|Pulmatrix - Utang jangka dawa marang modal|PTHL: Utang jangka dawa marang ekuitas|APM: Utang jangka dawa marang modal|LYRA - Rasio tanggungan utang jangka dawa marang modal|Utang jangka dawa marang ekuitas Impact BioMedical Inc|Kewajiban jangka dawa marang modal TNF Pharma TNFA|Rasio utang jangka dawa marang ekuitas YCBD (cbdMD, Inc.)|Rasio silihan jangka dawa marang modal PRFX|Utang jangka dawa marang modal CYTO (Altamira Therapeutics Ltd.)|Lipella Pharma (LIPO) - Kewajiban jangka dawa marang modal|OptiNose, Inc. - Utang jangka dawa marang modal|pieris.com (PIRS) - Rasio utang jangka dawa marang ekuitas|PROC: Utang jangka dawa marang modal|Petros Pharmaceuticals Inc - Koefisien utang jangka dawa marang modal|Rasio utang jangka dawa marang ekuitas QLI|SLRN: Koefisien utang jangka dawa marang modal|Utang jangka dawa marang ekuitas TFF Pharmaceuticals (TFFP)